Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

November 14, 2025






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities are owned directly by U.S. Venture Partners XII, L.P. ("USVP XII"). Presidio Management Group XII, L.L.C. ("PMG XII") is the general partner of each of the USVP XII Funds (as defined below) and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP XII Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the "Commission") on November 12, 2025 (the "Form 10-Q").


SCHEDULE 13G




Comment for Type of Reporting Person:   Consists of (i) 1,686,403 shares of Common Stock held directly by USVP XII, (ii) 85,587 shares of Common Stock held directly by U.S. Venture Partners XII-A, L.P. ("USVP XII-A", and together with USVP XII, the "USVP XII Funds"), and (iii) 921,131 shares of Common Stock held directly by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A"). PMG XII is the general partner of each of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI", and together with USVP XII and USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, the "U.S. Venture Partners") is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey, a member of the Issuer's board of directors, is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person:   Consists of (i) 1,686,403 shares of Common Stock held directly by USVP XII, (ii) 85,587 shares of Common Stock held directly by USVP XII-A and (iii) 921,131 shares of Common Stock held directly by U.S. Venture Partners USVP SFI, on its own behalf and as nominee for USVP SFI-A. PMG XII is the general partner of each of USVP XII and USVP XII-A. PMG SFI is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey, a member of the Issuer's board of directors, is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Form 10-Q.


SCHEDULE 13G



 
U.S. Venture Partners XII, L.P.
 
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025
 
Presidio Management Group XII, L.L.C.
 
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025
 
Casey M. Tansey
 
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025